Risk of Late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: Results from a randomized trial

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 5, 2014, Pages 1074-1084

  Hoffman, Karen E ^a   Voong, K Ranh ^a   Pugh, Thomas J ^a   Skinner, Heath ^a   Levy, Lawrence B ^a   Takiar, Vinita ^a   Choi, Seungtaek ^a   Du, Weiliang ^a   Frank, Steven J ^a   Johnson, Jennifer ^a   Kanke, James ^a   Kudchadker, Rajat J ^a   Lee, Andrew K ^a   Mahmood, Usama ^a   McGuire, Sean E ^a   Kuban, Deborah A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PARAMETERS; GASTROINTESTINAL TOXICITIES; INTENSITY MODULATED RADIATION THERAPY; INTENSITY-MODULATED; LATE RECTAL TOXICITIES; LOCALIZED PROSTATE CANCER; METHODS AND MATERIALS; RADIATION THERAPY ONCOLOGY GROUPS;

PHYSICAL THERAPY; RADIOTHERAPY; UROLOGY;

TOXICITY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BLADDER CAPACITY; BONE SCINTISCANNING; CANCER HORMONE THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATE VOLUME; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; RISK ASSESSMENT; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RADIOMETRY; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RISK; URINARY BLADDER;

EID: 84897891063     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.01.015     Document Type: Article

References (28)

1. D.A. Kuban, S.L. Tucker, and L. Dong et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
2. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
3. A.L. Zietman, M.L. DeSilvio, and J.D. Slater et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239
4. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101
5. D.J. Brenner, A.A. Martinez, and G.K. Edmundson et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
6. J. Fowler, R. Chappell, and M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
7. C.R. King, and J.F. Fowler A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low Int J Radiat Oncol Biol Phys 51 2001 213 214
8. A.A. Konski Less is more: Will hypofractionated radiotherapy negatively affect cancer centers or be a Godsend in the new health care environment? Oncology (Williston Park) 26 2012 522 523
9. P. Sethukavalan, P. Cheung, and C.I. Tang et al. Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: The benefits of hypofractionated over conventionally fractionated radiotherapy Can J Urol 19 2012 6165 6169
10. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
11. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557 discussion 1564
12. D.J. Brenner Fractionation and late rectal toxicity Int J Radiat Oncol Biol Phys 60 2004 1013 1015
13. S.L. Tucker, H.D. Thames, and J.M. Michalski et al. Estimation of alpha/beta for late rectal toxicity based on RTOG 94-06 Int J Radiat Oncol Biol Phys 81 2011 600 605
14. L. Budaus, M. Bolla, and A. Bossi et al. Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature Eur Urol 61 2012 112 127
15. NCCN Clinical Practice Guidelines in Oncology. Prostate cancer V2.2013. Available at NCCN.org. Accessed June 26, 2013.
16. N.G. Zaorsky, N. Ohri, and T.N. Showalter et al. Systematic review of hypofractionated radiation therapy for prostate cancer Cancer Treat Rev 39 2013 728 736
17. M. Ritter, J. Forman, and P. Kupelian et al. Hypofractionation for prostate cancer Cancer J 15 2009 1 6
18. E.F. Miles, and W.R. Lee Hypofractionation for prostate cancer: A critical review Semin Radiat Oncol 18 2008 41 47
19. A. Pollack, G. Walker, and E.M. Horwitz et al. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer J Clin Oncol 31 2013 3860 3868
20. P.A. Kupelian, V.V. Thakkar, and D. Khuntia et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes Int J Radiat Oncol Biol Phys 63 2005 1463 1468
21. P.A. Kupelian, T.R. Willoughby, and C.A. Reddy et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430
22. J.M. Michalski, H. Gay, and A. Jackson et al. Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
23. R. Malik, A.B. Jani, and S.L. Liauw External beam radiotherapy for prostate cancer: Urinary outcomes for men with high International Prostate Symptom Scores (IPSS) Int J Radiat Oncol Biol Phys 80 2011 1080 1086
24. A.A. Aizer, N.S. Anderson, and S.C. Oh et al. The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 79 2011 379 384
25. A. Harsolia, C. Vargas, and D. Yan et al. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study Int J Radiat Oncol Biol Phys 69 2007 1100 1109
26. M.J. Zelefsky, D. Cowen, and Z. Fuks et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468
27. M.R. Storey, A. Pollack, and G. Zagars et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial Int J Radiat Oncol Biol Phys 48 2000 635 642
28. L.J. Boersma, M. van den Brink, and A.M. Bruce et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms Int J Radiat Oncol Biol Phys 41 1998 83 92